1.73
1.76%
+0.03
Alpha Teknova Inc stock is currently priced at $1.73, with a 24-hour trading volume of 23,753.
It has seen a +1.76% increased in the last 24 hours and a -30.80% declined in the past month.
The chart indicates a potential bearish trend, as the stock is below the $1.75 pivot point. If it approaches the $1.65 support level, significant changes may occur.
Previous Close:
$1.70
Open:
$1.71
24h Volume:
23,753
Market Cap:
$70.62M
Revenue:
$36.71M
Net Income/Loss:
$-39.42M
P/E Ratio:
-0.9454
EPS:
-1.83
Net Cash Flow:
$-36.30M
1W Performance:
-13.50%
1M Performance:
-30.80%
6M Performance:
-8.95%
1Y Performance:
-12.63%
Alpha Teknova Inc Stock (TKNO) Company Profile
Name
Alpha Teknova Inc
Sector
Phone
831-637-1100
Address
2290 Bert Drive, Hollister
Alpha Teknova Inc Stock (TKNO) Latest News
Down -28.04% in 4 Weeks, Here's Why Alpha Teknova (TKNO) Looks Ripe for a Turnaround
Zacks Investment Research
Teknova Reports Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire Inc.
Teknova to Report Fourth Quarter and Full Year 2023 Financial Results on March 11, 2024
GlobeNewswire Inc.
Teknova Reports Third Quarter 2023 Financial Results
GlobeNewswire Inc.
Alpha Teknova Inc Stock (TKNO) Financials Data
Alpha Teknova Inc (TKNO) Revenue 2024
TKNO reported a revenue (TTM) of $36.71 million for the quarter ending September 30, 2023, a -15.88% decline year-over-year.
Alpha Teknova Inc (TKNO) Net Income 2024
TKNO net income (TTM) was -$39.42 million for the quarter ending September 30, 2023, a -4.22% decrease year-over-year.
Alpha Teknova Inc (TKNO) Cash Flow 2024
TKNO recorded a free cash flow (TTM) of -$36.30 million for the quarter ending September 30, 2023, a +31.87% increase year-over-year.
Alpha Teknova Inc (TKNO) Earnings per Share 2024
TKNO earnings per share (TTM) was -$1.37 for the quarter ending September 30, 2023, a -1.48% decline year-over-year.
About Alpha Teknova Inc
Alpha Teknova, Inc. provides reagents for bioprocessing, bioproduction, and molecular diagnostics. The company's reagents enable the discovery, research, development, and production of biopharmaceutical products, such as drug therapies, novel vaccines, and molecular diagnostics. It offers liquid culture, dry culture, agar, and animal-free media, as well as pre-poured plates, biological buffers, solutions, chemicals, and various treated and certified waters. The company was founded in 1996 and is based in Hollister, California.
Cap:
|
Volume (24h):